First American Bank Has $213,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

First American Bank trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 48.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 524 shares of the company’s stock after selling 500 shares during the quarter. First American Bank’s holdings in HCA Healthcare were worth $213,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of HCA. Terra Nova Asset Management LLC raised its holdings in HCA Healthcare by 0.3% in the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after acquiring an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its position in HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares during the period. Waldron Private Wealth LLC increased its holdings in HCA Healthcare by 1.8% in the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after buying an additional 29 shares during the period. Brookstone Capital Management boosted its position in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares in the last quarter. Finally, UMB Bank n.a. raised its position in HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 8.9 %

NYSE HCA opened at $363.55 on Monday. The stock has a market capitalization of $95.22 billion, a P/E ratio of 18.12, a P/E/G ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a one year low of $220.55 and a one year high of $417.14. The business has a 50 day simple moving average of $395.06 and a 200 day simple moving average of $352.71. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 13.16%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent analyst reports. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a report on Tuesday, October 22nd. KeyCorp started coverage on shares of HCA Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $475.00 target price on the stock. Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Finally, StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Five investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and four have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $377.17.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.